| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  HemostOD Inspired by platelet biology to save lives. We engineer and manufacture platelets. platelets, biotechnology, bioengineering, stem cells, on demand, biodrug, in vitro manufacturing, Bioprocess, blood platelets, alloimmunization, thrombocytopenia, blood cancer, leukemia, transfusion, HSCT, Stem cell, Hematology, biologics, drug, biopharma, drug development, healthcare, allogenic therapy, drug delivery, miRNA, siRNA, targeted delivery, and targeted drug delivery Type: | 2 | 0 | 0 | 9 |
 |  BioPorto Diagnostics A/S BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem. The Company’s flagship products are based on the NGAL biomarker and designed … Type: | 0 | 0 | 0 | 47 |
 | Bright Peak Therapeutics Better Biologics Through Chemistry Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases. Through a variety of proprietary technology platforms, Bright Peak is uniquely abled to conjugate its cytokines as payloads to antibodies, creating bespoke, novel and proprietary “Bright Peak Immunocytokines”, and to other cytokines as “duokines”. The Bright Peak Immunocytokines allow tissue- and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy. One of the many advantages of our approach is its "off-the-shelf" feature. Using a pioneering site-specific ADC-like chemical … Type: | 1 | 0 | 0 | 55 |
 | Augustine Therapeutics Innovative Therapies for Neuromuscular and Neurodegenerative Disorders Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT), peripheral neuropathies and neurodegenerative disorders. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by Asabys Partners, Eli Lilly and Company, V-Bio Ventures, PMV, AdBio Partners, VIB, Gemma Frisius Fund and CMT Research Foundation. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge … Type: | 0 | 0 | 0 | 15 |
 |  Medannex Ltd Award-winning Scottish biopharmaceutical company, advancing the treatment of cancers and autoimmune diseases. Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. Our goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of our patent-protected immunomodulatory technology. Antibody development, Innovation, Biotechnology, T cell modulation, Skills development, Autoimmune diseases, Inflammation, Lupus, SLE, Collaboration, … Type: | 2 | 0 | 2 | 10 |
 | Herantis Pharma Plc. Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s. Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’ lead product HER-096, is an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein. It combines the compelling mechanism of action of CDNF with the convenience of subcutaneous administration. A Phase 1a clinical trial has demonstrated a good safety and tolerability profile, and efficient blood-brain barrier penetration of subcutaneously administered HER-096 in humans. The shares of Herantis are listed on the Nasdaq First … Type: | 1 | 0 | 1 | 21 |
 | e-therapeutics PLC Computing the future of medicine A specialist in computational drug discovery with a focus on developing RNA interference (“RNAi”) therapeutics Type: | 0 | 0 | 0 | 52 |
 | PharmNovo Innovation in pain relief PharmNovo AB is a clinical-stage pharmaceutical company focused on developing safe and effective drugs for neuropathic pain. In this area, there is currently a lack of sufficient treatments. The company’s drug candidate, PN6047, effectively reduces neuropathic pain in animal models and the findings from the Phase I trial show that PN6047 is safe and well-tolerated at the doses tested, with no serious adverse events reported. Furthermore, PN6047 exhibited none of the adverse events typically associated with the conventional opioids like oxycodone and morphine, such as respiratory depression, constipation, itching, or signs of abuse potential. This validates … Type: | 0 | 0 | 0 | 10 |
 | CellCentric Developing inobrodib (CCS1477), first-in-class p300/CBP inhibitor to treat specific cancers. Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally. p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers. CellCentric’s pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise … Type: | 2 | 1 | 1 | 23 |
 | 4D Biomaterials 4Degra® 3D printing biomaterials - helping people heal. Regenerative, resorbable and customisable. The market for polymeric biomaterials is growing quickly, but despite this growth, it is widely recognised in the industry that the ‘holy grail’ solution has not yet been developed. The ideal biomaterial for use in regenerative medicine must: be biocompatible; promote tissue regeneration; have non-toxic biodegradation, have mechanical properties suited to the host tissue and good handling properties in a clinical environment. Our people have developed a patented range of novel polymeric 3-D printing resin-inks that promise, uniquely, to meet all of the above requirements and offer important … Type: | 0 | 0 | 0 | 9 |
 | ARGONAUTE RNA LIMITED Argonaute RNA Ltd. is developing safe and reliable methods of temporarily silencing target genes in different tissue cells. Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. Argonaute RNA research projects build on existing intellectual property. We show how our proprietary modification of small interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression. We use a novel method of stabilising the siRNA and thereby avoid a range of issues which have … Type: | 0 | 0 | 0 | 10 |
 | Integra Therapeutics Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases At Integra Therapeutics we have combined the precision of CRISPR systems with the gene transfer efficiency of viral integrases and transposases. Harnessing what nature has evolved to introduce large pieces of DNA into the genome, together with the precision of sequence specific DNA binding proteins, has allowed for unprecedented efficiency in programmable gene delivery. Type: | 2 | 1 | 1 | 20 |
 | Draupnir Bio Bringing innovative therapies to patients Draupnir Bio is a Danish biotechnology company driven by a deep commitment to scientific excellence and the desire to bring innovative therapies to patients in need. By harnessing the natural machinery of the lysosome, we are developing oral, small molecule degraders of extracellular pathogenic proteins – the next frontier of targeted protein degradation (TPD), a rapidly emerging field that exploits a cell’s own destruction machinery to tackle disease-causing proteins that have historically been highly challenging to target with conventional therapies. First-generation TPD approaches are exclusively limited to intracellular targets, leaving extracellular and membrane-bound proteins – … Type: | 0 | 0 | 0 | 16 |
 | Pan Cancer T Pan Cancer T is a biotechnology company developing T cell receptor (TCR) T-cell therapy for solid tumors. Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges. Type: | 1 | 1 | 0 | 9 |
 | SciRhom Targeting iRhom2 for better treatment of autoimmune diseases SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases. drug … Type: | 3 | 2 | 2 | 16 |
 | Asceneuron SA Targeting the root cause of neurodegeneration Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson’s Disease, Alzheimer’s disease and related disorders. Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & … Type: | 3 | 2 | 2 | 20 |
 | Akadeum Life Sciences, Inc. Better Isolations. Healthier Cells. Akadeum Life Sciences® has developed a next generation platform that solves long-standing problems across cell therapy and other research, diagnostic and therapeutic markets. The proprietary buoyant microbubble technology platform addresses the need for high cell quality, scalability, time and workflow that current magnetic particle-based products commonly used in cell therapy manufacturing and research can’t address. The Company has several GMP grade and Clinical Ready kits to enable each stage of cell therapy manufacturers pipeline. Harnessing the microbubble capability, the AlerionTM Microbubble Cell Separation System enables cell isolation from tens of billions of cells in apheresis material … Type: | 1 | 1 | 0 | 31 |
 | Delphinus Medical Technologies, Inc. Delivering medical innovations to transform early detection of breast cancer and save women’s lives all over the world. Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Called SoftVueTM, and featuring proprietary TriADTM (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals … Type: | 1 | 1 | 0 | 65 |
 | Inscripta, Inc. The Digital Genome Engineering Company Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California. To learn more, visit Inscripta.com and follow @InscriptaInc. Digital Genome Engineering, Gene Editing, Synthetic Biology, Genome Editing, CRISPR, … Type: | 4 | 1 | 3 | 74 |
 | Turbine We are building the world’s leading predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s leading predictive simulation of patient biology. We will empower the biopharma industry by informing the right experiments that identify and validate disease driving hidden effects. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals Type: | 5 | 0 | 5 | 101 |
 | Insilico Medicine #insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. artificial intelligence, deep learning, reinforcement learning, drug discovery, … Type: | 20 | 2 | 17 | 295 |
 | The Medicine Maker The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form Type: | 29 | 6 | 27 | 1 |
 | Immunocore Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI Type: | 9 | 3 | 1 | 538 |
 | Crescendo Biologics Limited Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical … Type: | 5 | 3 | 4 | 50 |
 | Newcells Biotech Ltd In vitro models to accelerate clinical translation We’re here to accelerate your therapy’s journey through the complexities of drug discovery and development. Putting innovation at the forefront of our capabilities, industry-leading experts help you confidently and proactively answer critical questions around the safety and efficacy of your product with our gold-standard in vitro models. By harnessing the power of predictive data, we navigate this crucial step efficiently and cost-effectively to maximise the potential of your therapy achieving clinical and market success. By combining our unique expertise with cutting-edge technologies, we’ve created predictive in vitro models that offer targeted solutions to … Type: | 1 | 0 | 1 | 47 |
 | Genomics plc Transforming health, healthcare and drug discovery through the power of genomics We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalized estimates of risk for all the common diseases and cancers, well ahead of … Type: | 12 | 4 | 11 | 148 |
![LCC [Liverpool ChiroChem]](/media/logo/101424.jpeg){kind=logo} | LCC [Liverpool ChiroChem] Bring new compounds to market faster, better, and easier. Liverpool ChiroChem is an international, chemical technology innovator, on a mission to accelerate the discovery and development of high-quality drugs. LCC was established in Liverpool, United Kingdom, in June 2014. The company has developed a suite of synthetic methodologies that have been used to produce thousands of novel, multifunctional 3D-rich, chiral fragments/scaffolds/BB’s to support NCE discovery & development (e.g. Fragments, DEL, VLS, Bifunctional Linkers). LCC is continuously expanding its 3D chemical space and has recently launched a 1.4Bn member Ultra-Large Virtual Library designed based on its proprietary scaffolds and supported by … Type: | 2 | 0 | 0 | 30 |
 | Evox Therapeutics Ltd Naturally inspired. Engineered to deliver Evox Therapeutics is harnessing and engineering the natural trafficking capabilities of extracellular vesicles to develop an entirely novel class of biotherapeutics. By combining groundbreaking exosome technology from well-renowned Oxford University and the Karolinska Institutet – the home of the Nobel Prize – we aim to revolutionise the treatment of a broad range of severe disease, with profound implications for human health. Based in Oxford, UK, Evox Therapeutics was founded in 2016 by Professor Matthew Wood of Oxford University, Assistant Professor Samir EL Andaloussi and Dr Per Lundin of the Karolinska Institutet, to capitalise on foundational … Type: | 6 | 2 | 0 | 53 |
 | Closed Loop Medicine Treating the individual, not just the disease, through personalized and optimized dosing. We need to shift to a world where we treat the individual, not just the disease. Our inventions work in combination with medicine to deliver personalized, optimized dosing, to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases. Closed Loop Medicine is a TechBio company developing combination prescription drug + software products, with the aim of bringing forward the promise of precision care. Our proprietary technology platform facilitates personalized drug dose optimization through integration of medicines and software with patient-led digital experiences and closed … Type: | 10 | 1 | 5 | 54 |
 | CSV Experts Always Meeting the Standards Computerized Systems Validation Experts. Consultancy services for healthcare regulated companies with regards computerized systems validation in GXP environments. The most valued services delivered in compliance with EU GMP and 21 CFR Part 11. Contact at info@csvexperts.com Strategies for the fulfillment of the GMP and GDP regulations, Strategies for the fulfillment of regulatory needs and quality assurance in the areas of R&D, Medical Devices, IT Compliance, Audits, and Business training Type: | 2 | 1 | 1 | 7 |
 | McSAF Chemical tools for bioconjugaison & biodrugs McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies. Its core expertise covers Therapeutic Peptides and Proteins, Antibodies, and Drug Conjugates. The team has a strong background in synthetic selective chemistry, and a real expertise in bioconjugation, including specific designs of Antibody Drug Conjugates (ADCs) with own proprietary coupling technology. Plus, the company has now a pipeline of three products in oncology incorporating McSAF Inside technology with the ambition to bring new biodrugs on the market solving unmet medical needs. Bioconjugation, Biopharmaceuticals, Antibody Drug Conjugates, … Type: | 1 | 1 | 0 | 6 |
 | Molecular Devices Advancing Discovery Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over … Type: | 3 | 1 | 2 | 765 |
 | Medscape The leading online global destination for physicians and healthcare professionals: https://wb.md/2EPrMgZ Our Mission: To improve patient care with comprehensive clinical information and resources essential to physicians and healthcare professionals. Our Company: Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME. Medscape has over 30 distinct specialty sites for physicians, plus sites for nurses, pharmacists, dentists, and medical students. All content on Medscape.com and Medscape.org is available for free. medical news, medical reference, and continuing medical education Type: | 12 | 5 | 3 | 762 |
 | Viridos See how algae moves us. Viridos is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineers are shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com. Synthetic Biology, Fermentation, Next Generation Genomics, Bioprocessing, Bioinformatics, Cell Optimization, Biodiscovery, Advanced Engineering, … Type: | 5 | 0 | 5 | 83 |
 | Medicago La santé est dans notre nature | Health is in our nature. Medicago develops vaccines and treatments to help fight emerging global health challenges, today and in the future. Please note that we may come across a situation not outlined above that will require the removal of your comment. Please know that Medicago reserves the right to delete any comment at its sole discretion. If you feel your comment has been unfairly removed, please contact us. For information about our commenting guidelines, please visit: http://ow.ly/6mKh50HKyUR Medicago développe des vaccins et des traitements pour répondre rapidement aux nouveaux défis de santé … Type: | 5 | 0 | 1 | 180 |
 | Medgadget Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004. Medgadget is an independent publication and is published by a group of MDs and biomed engineers. If you have collaboration ideas or entrepreneurial experience that you want to bring to our company's attention, we want to hear from you. We believe that possibilities at Medgadget are endless! medical devices, medical discoveries, medical technology, conferences, medicine, events, and publishing Type: | 3 | 0 | 0 | 10 |
 | Master Spas Get the backyard oasis you’ve always wanted with a Master Spas ultra-therapeutic hot tub or swim spa Master Spas is based in Fort Wayne, Indiana, 90 miles northeast of Indianapolis. Operating out of a state-of-the-art, 530,000-square-foot manufacturing facility on a 36-acre manufacturing campus, Master Spas is the largest swim spa manufacturer in the world, and largest portable hot tub manufacturer that makes 100% of our product in the USA. The company’s executive team boasts more than 200 years of spa manufacturing success and one of the strongest track records in the industry. The company is committed to helping people live … Type: | 0 | 0 | 0 | 188 |
 | Marymound Helping youth and families with the challenges of growing and learning to achieve independence while realizing their full potential. Clinical Therapy, Group Homes, Sexual Exploitation, Crisis Stabilization, Special Needs Education, Drug Addiction, Independent Living, Young Parents, Mental Health, Foster Care, Sexual Abuse, and Employment Training Type: | 2 | 1 | 1 | 148 |
 | Optomed Plc Finnish MedTech company and a leading provider of handheld fundus cameras enabling screening for all. Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Our AI-powered screening solutions aim to transform diagnostic processes of various diseases, empower early detection, and improve people’s health through innovations. Two decades of pioneering expertise, we design cutting-edge retinal imaging technology that is trusted by healthcare professionals worldwide. Our technology is extensively patented, clinically validated and has approvals in all key markets, including CE, FDA and CFDA. Our products are sold via various sales channels in over 60 countries … Type: | 0 | 0 | 0 | 90 |
 | Integrum AB Improving life for amputees through bone-anchored prostheses, healthy soft tissue and relief of phantom limb pain. Integrum has since the start in 1998 been helping individuals with amputations towards an improved quality of life. A thorough experience in osseointegration has generated a system for bone-anchored prostheses – a beneficial alternative to the traditionally used socket prosthesis. Integrum is world leading in this area, with patients from all parts of the world treated in centers of excellence. Performing continuous research and development, Integrum aims at providing safe medical devices and supporting a more active lifestyle for those experiencing limb loss. In … Type: | 0 | 0 | 0 | 63 |
 | CHEPLAPHARM A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty … Type: | 1 | 0 | 0 | 417 |
 | Laboratoire Shadeline [Automatic translation follows] Development & production of safe and effective medical devices and dermo-cosmetic products for the whole family. SHADELINE Laboratory is an entity of the ANJAC HEALTH & BEAUTY Group. Specialized in Research & Development and Production of dermocosmetic, parapharmaceutical products and medical devices for topical use. Characterized by a high level of technicality and quality, the laboratory is certified ISO 22716 (GMP cosmetics) and ISO 13485 (Design, Development and Production of Medical Devices). SHADELINE creates and manufactures all types of innovative and effective formulations for dermatological products: Baby products, sun products, hygiene and beauty products, skin disorder correction … Type: | 0 | 0 | 0 | 28 |
 | Europhartech - A Dômes Pharma Company [Automatic translation follows] Europhartech, a company of the Dômes Pharma Group Production site of the Dômes Pharma Group EUROPHARTECH is also a CMO (Contract Manufacturing Organization) for the Human and Veterinary Pharmaceutical Industry. Specialized in clinical batches, the production of dry forms and non-sterile liquid forms for human and veterinary use as well as in food supplements, complementary foods and medical devices. EUROPHARTECH also has solid expertise in the originator markets, ATU/AMM hospital and EHPAD unit BUD, PDA, generic and nutraceutical. EUROPHARTECH is a subsidiary of the DÔMES PHARMA Pharmaceutical Group historically specialized in Animal Health and present in Human … Type: | 2 | 1 | 0 | 75 |
 | C4X Discovery Ltd Pioneering drug discovery company exploiting cutting edge technologies to create best-in-class small molecule medicines C4XD is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‐leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. The Company was founded as a spin-out from the University of Manchester. It has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically and have enabled C4XD … Type: | 7 | 1 | 4 | 47 |
 | Cumulus Neuroscience Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience. Type: | 5 | 2 | 0 | 33 |
 | Healthy Performance Ltd Employee Health and Wellbeing Specialists We are passionate about improving employee health and wellbeing through our range of innovative and easy to use workplace solutions. With powerful reporting and insight tools we can help to maximise the impact of wellbeing solutions which ultimately leads to happy and healthy employees. We provide onsite health assessments, online lifestyle and mental health checks, onsite health promotion events, wellbeing workshops and webinars, flu vaccination services and Covid-19 antibody testing services. All of our onsite staff follow strict PPE processes and protocols in line with Public Health England to ensure Covid-19 workplace safety. Our in-depth … Type: | 3 | 1 | 1 | 35 |
 | Aqdot Limited The Supramolecular Chemistry Company Aqdot is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products. The Aqdot Solutions part of the business works in partnership with customers to understand their challenges and develop solutions utilising the unique AqBit technology. This has the team working in areas from air filtering in transportation to delivery of therapeutics for cancer. In parallel the Aqdot Products part of the company has recently launched its own brands AqStarTM M1 and Oderase to date. Again, working with partners either on a distribution basis, or offering the … Type: | 2 | 1 | 1 | 30 |
 | CytoSeek A cell-therapy technology company developing artificial membrane-binding proteins for oncology and regenerative medicine CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. Our novel cell membrane augmentation technology enables us to add new functionalities to various therapeutic cells. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health. Biochemistry, Immunology, Oncology, Regenerative Medicine, Cell therapies, and Proteins Type: | 0 | 0 | 0 | 2 |
 | Corin Group Helping orthopaedic surgeons enhance patient well-being with our proven implants, connected technologies and data. As a leader in orthopaedic innovation, Corin has pioneered a number of landmark developments since its foundation and is proud to have been able to improve the quality of life of thousands of patients around the world through these groundbreaking products. The company’s talented and dedicated teams share a common commitment to deliver quality orthopaedic products and services to patients, surgeons and healthcare providers which exceed expectations and positively impact lives. With an increasingly active and demanding patient population, the need to provide state of the … Type: | 1 | 0 | 0 | 712 |
 | Venomtech Ltd Our goal at Venomtech is to lead the way towards an era where venom-based research tools are routinely used as sources Venomtech targeted arrays provide a unique opportunity to identify novel screening tools and discover novel therapeutics. Animal venoms are a complex mix of peptides, small molecules and proteins that bind, activate, inhibit or otherwise modulate molecular targets such as ion channels, GPCRs and kinases. Screening crude venoms to identify bioactive components is made extremely difficult by a large number of potentially conflicting activities (e.g. cytotoxins masking pharmacology) and de-convolution challenges. In the past, these challenges have hampered many of … Type: | 2 | 0 | 2 | 6 |
 | CERHUM Bone graft 3D-printing | bioceramics | R&D | CDMO activities CERHUM AT A GLANCE: We are a Belgian company which manufactures human bone grafts made of bio ceramics and act as a Medical Device CDMO, providing thousands of parts and developments as a subcontractor for big players, mainly in orthopedic surgeries. ---------------------------LEARN MORE---------------------------------- CERHUM manufactures medical devices using additive manufacturing (3D printing) in combination with advanced and innovative materials. With a 10 year-experience of industrial and in-house R&D, CERHUM has applied these additive manufacturing capabilities to bioceramics and in particular hydroxyapatite which is a well-known, tried and tested material in … Type: | 0 | 0 | 0 | 23 |
 | Pi-Cardia Leading the way for leaflet modification Pi-Cardia is a medical device company and market leader in the development of a broad portfolio of leaflet modification solutions for treating heart valves. The company has years of knowledge and expertise accumulated in degenerated valves, including calcification patterns, mode of valve failure, and impact of various methods of leaflet modification. ShortCutTM is designed to provide a safe, simple, and effective way to split leaflets of a pre-existing valve to enable TAVR in patients at risk for coronary obstruction and may assist in preserving coronary access. Medical Device, Aortic Stenosis, Precautions Catheter-System, Cardiovascular, leaflet … Type: | 2 | 1 | 1 | 58 |
 | The Healthy Pet Company The best health care for your pet. Join today to spread the cost. Our pet health care plans for cats, dogs, rabbits, puppies and kittens help you to save money on your pet’s vital preventative health care. Type: | 0 | 0 | 0 | 1 |
 | VETS IN THE CITY Pet Care Remaining your partner for honest, compassionate and complete pet healthcare. Our services and facilities have been designed to assist in all routine preventative care for young, healthy pets; early detection and treatment of disease as your pet ages; and complete medical and surgical care as necessary during their lifetime. veterinary Type: | 0 | 0 | 0 | 6 |
 | Jelmar, LLC Been There. Outdone That.TM Jelmar manufacturers CLR Brands and Tarn-X branded cleaning products. These products are available in food, drug and mass retailers. Jelmar has been a growing, evolving company since its inception in 1949. The company began when Manny Gutterman established a national sales representative organization, Manny Gutterman & Associates, Inc. This new company was dedicated to selling all types of proprietary products to chain drug, variety, hardware and department stores. Tarn-X® Tarnish Remover, during the late 1960s, became one of the first products that used the phrase “AS SEEN ON TV” in commercials and on packaging. Tarn-X has … Type: | 0 | 0 | 0 | 30 |
 | F-star, an invoX company A clinical-stage biopharma developing next gen bispecific antibodies to transform the lives of patients with cancer. F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneering bispecific antibodies in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star has four second-generation immunooncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-star’s proprietary antibody … Type: | 7 | 1 | 4 | 43 |
 | Hendrix Genetics Better Breeding Today. Brighter Life Tomorrow. Hendrix Genetics is a leading multi-species animal breeding company with primary activities in layer-, turkey-, traditional poultry-, swine-, trout and salmon breeding. Backed by a strong portfolio of leading brands, Hendrix Genetics provides expertise and resources to producers in more than 100 countries, with operations and joint ventures in 24 countries and more than 2.880 employees worldwide. Creating value with genetics is the essence of our existence. The three key components of how we create value for the animal protein chain are: collaboration, innovation and sustainability. We see collaboration as a key factor in … Type: | 3 | 1 | 0 | 669 |
 | Horus Pharma Horus Pharma is an independent French laboratory specialised in ophthalmology. Founded in 2003, Horus Pharma develops, patents and markets products designed to facilitate eye and eyelid health. Horus Pharma operates in most segments related to ophthalmology and develops practical innovations that combine efficacy and safety. Read our community guidelines https://bit.ly/HPCommunityGuidelines Focused on patient safety, our laboratory has developed recognised expertise in the development of preservative-free formulations and product delivery systems. The product portfolio at the laboratory includes medicinal products, medical devices and food supplements. With its new Surgery Division, Horus Pharma is pursuing its growth by offering surgical and peri-surgical … Type: | 20 | 4 | 18 | 245 |
 | CYRANIE NUTRITION [Automatic translation follows] For 20 years, Cyranie has made taste its central concern, our very diversified products adapt to the appetites and requirements of each person and promote the pleasure of eating. Cyranie develops, manufactures and markets a range of dehydrated food mixes. Cyranie has always based its approach on taste and nutritional qualities in accordance with French tradition and culinary know-how. We are manufacturers, our products are exclusive and developed by our R&D department in close collaboration with our customers. Cyranie has veterinary approval, works according to the HACCP method and since 2014 has obtained the IFS v6 superior … Type: | 3 | 1 | 2 | 6 |
 | Crystal Pharmatech A Leading CRO/CDMO for Solid Form & Formulation, Advancing Your PCC to Phase I and Beyond with First-Time-Right Approach Established in 2010, Crystal Pharmatech is a specialized CRO/CDMO, excelling in crystal form and formulation services. Our exceptional track record includes supporting 1,000 clients and collaborating on over 2,000 compounds, showcasing our expertise in solid-state research, crystallization, pre-formulation, formulation development, and manufacturing. With a global presence encompassing three strategically located R&D centers in New Jersey (USA), Toronto (Canada), and Suzhou (China), we are powered by a skilled team of around 250 professionals. As a leader in both conventional and enabling formulation … Type: | 5 | 0 | 5 | 73 |
 | SpyBiotech Utilizing unique protein superglue technology to develop vaccines against infectious disease and cancer worldwide SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year. Vaccine Development Type: | 3 | 2 | 1 | 23 |
 | Discovery Park A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, … Type: | 21 | 1 | 20 | 62 |
 | Qkine High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and cellular agriculture Qkine manufactures high-quality and novel growth factors, supporting scientists in developing and scaling stem cell, organoid, cellular agriculture and regenerative medicine applications. We are also developing new growth factor technologies to enable emerging fields such as cultured meat and 3D cell culture. All Qkine high purity animal-free growth factor proteins are manufactured at our facility in Cambridge, UK . Extensive quality testing is conducted on every lot to guarantee reproducibility. Based on proprietary technology developed in the laboratory of Dr Marko Hyvönen, senior … Type: | 9 | 3 | 9 | 39 |
 | Prokarium LIVING CURES Prokarium is pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects. Biotechnology, Vaccines, Oral delivery, Immunology, Synthetic Biology, Oncology, Microbial Immunotherapy, and Immunotherapy Type: | 5 | 0 | 2 | 22 |
 | Compass Pathways Our vision is a world of mental wellbeing We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression. We want to transform the patient experience in mental health care. Type: | 10 | 2 | 3 | 249 |
 | Deep Branch (acquired by Aerbio 2024) Deep Branch was established in Nottingham (UK) in 2018 and built a gas fermentation platform for protein production. Deep Branch developed a patented technology platform that use carbon dioxide and hydrogen as feedstocks for fermentation, instead of sugar. The company was acquired by Aerbio in 2024. Carbon recycling, Single cell protein, Gas fermentation, Synthetic biology, Circular economy, Biobased economy, and Food Security Type: | 17 | 2 | 12 | 12 |
 | Jellagen A Revolutionary Platform for Regenerative Medicine Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications. Medical Grade Collagen, Native Collagen, Cell Culture Reagents, Wound Healing, Hydrogels, Non Mammalian Collagen, Collagen, Reagents, Marine Biotechnology, regenerative medicine, 3dscaffolds, collagencoatedplates, and 3dsponges Type: | 2 | 0 | 2 | 15 |
 | MeiraGTx Engineering Hope MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicine company with a broad pipeline of late-stage clinical programs supported by end-to-end manufacturing capabilities. MeiraGTx has an internally developed manufacturing platform process, internal plasmid production for GMP, two GMP viral vector production facilities as well as an in-house Quality Control hub for stability and release, all fit for IND through commercial supply. MeiraGTx has core capabilities in viral vector design and optimization and a potentially transformative riboswitch gene regulation platform technology that allows for the precise, dose-responsive control of gene expression by oral small molecules. MeiraGTx is focusing … Type: | 4 | 1 | 3 | 383 |
 | Motilent Changing the way we see the gut Motilent is a technology SME focused on delivering innovative services for the quantitative investigation of the gut. Motilent champions the use of novel MRI post-processing software as a cheaper and safer biomarker for Gastrointestinal and Bowel Disorders, providing quantitative end points for research, drug development and clinical decision-making. Type: | 6 | 1 | 6 | 21 |
 | Repositive - no longer trading Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners Repositive is committed to accelerating the development of precision cancer therapies to the clinic by working with biopharmas and Contract Research Organisations (CROs) to improve the predictivity of pre-clinical cancer research. Through its Cancer Models Scout service, Repositive is helping biopharmas to optimise their pre-clinical cancer projects by identifying the most suitable cancer models for their requirements from its world-leading database of over 8000 models, as well as via outreach to an extended network of CRO contacts. Repositive works to connect researchers with the right … Type: | 9 | 2 | 7 | 1 |
 | Foundry3 Healthcare communications agency built on the three pillars of science, creativity and innovation We are a global healthcare communications agency built for a connected world. We seamlessly integrate online and offline channels to engage, educate and inform healthcare professionals and patients. We are driven by data, insight and robust science. Yet we communicate with passion, flair and empathy. Some clients use us as a medical agency, creative agency or digital agency. Regardless, we always bring all three disciplines to each and every project, just in different doses. You give us the challenge, and we build the solution around it. Medical … Type: | 3 | 1 | 0 | 10 |
 | The Electrospinning Company Ltd. Bringing Your Medical Device Design to Life. Electrospun Material Development, Validation, and Scale-Up We assist medical device manufacturers at every stage of their material development journey. From conducting feasibility studies to scaling up of your validated manufacturing process, we ensure that as the demand for your device grows, your electrospun material manufacturing process does, too. Since 2014, we have been transforming material concepts into scalable electrospun device material manufacturing processes that meet quality requirements. Our expertise lies in converting design requirements into medical-grade electrospun materials and components. We guide clients throughout their material development journey, starting with a feasibility study, … Type: | 3 | 1 | 2 | 21 |
 | Lightpoint Improving patient outcomes with targeted cancer surgery Lightpoint is a technology leader in precision-guided robotic cancer surgery. We are developing miniaturized imaging and sensing tools for advanced intra-operative cancer detection. Our mission is to improve the lives of people with cancer by transforming the efficacy of robotic surgery. Lightpoint Medical was established in 2012 and in 2023 was acquired by Telix Pharmaceuticals and became Lightpoint - a Telix Company. https://telixpharma.com/news-views/telix-completes-acquisition-of-lightpoint-medical Medical imaging, Image-guided surgery, Molecular imaging, Surgical imaging, Intraoperative imaging, PET imaging, Surgical navigation, Medical device, robotic surgery, surgical robotics, robotics, and medtech Type: | 6 | 1 | 2 | 13 |
 | Idorsia Pharmaceuticals Ltd Reaching out for more! The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://www.idorsia.com/documents/com/policies-charters/idorsia-linkedin-community-guidelines.pdf Idorsia … Type: | 1 | 1 | 0 | 995 |
 | Pet Drugs Online The UK's largest and most-trusted supplier of veterinary medicine and pet products. Helping you to love them well. Pet Drugs Online originated in the office of a small Bath veterinary surgery in 2005, with a simple yet ambitious goal: to help pet owners drastically reduce the cost of their pet healthcare. Over the course of 15 years, we have grown to become the largest and most trusted supplier of veterinary medicine in the UK, assisting millions of customers in finding the medicines, supplements, and food their pets need. At our core, we are not only pet owners, but passionate pet … Type: | 0 | 0 | 0 | 66 |
 | TWIICE Enabling people to reconnect with their community by giving back access to life. TWIICE is an early stage start-up based in Lausanne, Switzerland. We develop and build customer-specific exoskeletons for walking assistance and rehabilitation of people with mobility issues. Our goal is to give back users the sensations and benefits of standing and walking as well as help them regain some independence in their daily activities. Type: | 7 | 2 | 4 | 8 |
 | Genenta Science Permanent Self-Vaccination Against Cancer Genenta (Nasdaq: GNTA) is a clinical-stage biotechnology company engaged in the development of a proprietary hematopoietic stem cell therapy for the treatment of a variety of solid tumor cancers. TemferonTM is based on ex-vivo gene transfer into autologous Tie2+ hematopoietic stem/progenitor cells (HSPCs) to deliver immunomodulatory molecules directly via tumor-infiltrating monocytes/macrophages (Tie2 Expressing Monocytes - TEMs). Temferon, which is under investigation in a phase 1/2a clinical trial in newly diagnosed Glioblastoma Multiforme patients who have an unmethylated MGMT gene promoter (uMGMT-GBM), is designed to reach solid tumors, induce a durable immune response not restricted to pre-selected … Type: | 7 | 0 | 2 | 25 |
 | Standard BioTools Providing essential, standardized tools to accelerate breakthroughs in human health Microfluidics | Cytometry | Imaging Fluidigm is now Standard BioTools. A company and a name that reflects our commitment to you and your research ... To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better. We are evolving to better meet the needs of our customers, bridging a robust and established portfolio of next-generation technologies with an experienced team of leaders dedicated to operational excellence. Standard BioTools – Unleashing reliable tools to accelerate breakthroughs in human health • Providing trusted … Type: | 6 | 1 | 6 | 965 |
 | Oncimmune We understand disease through the lens of the immune system for more effective, safer treatments & better diagnosis Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based platform, delivers actionable insights into therapies to our pharmaceutical and biotech partners. Oncimmune’s ImmunoINSIGHTS platform enables life-science organisations to optimise drug development and delivery, leading to more effective targeted as well as safer treatments for patients. Oncimmune is headquartered in the UK, with a discovery research centre in Dortmund, … Type: | 8 | 0 | 7 | 51 |
 | Kuano Providing innovative quantum and AI solutions for drug discovery and design. Our discovery platform uniquely combines target quantum mapping and AI led chemistry to enable faster development of better drug candidates. Our unique approach tackles common challenges in both AI driven drug design and target driven drug discovery. Quantum Mapping of targets introduces selectivity from the start, producing superior candidates in fewer design rounds. Identifying better starting points for AI-led chemistry eliminates bottlenecks in the hit to candidate optimization phase. Generating better Enzyme Inhibitors by targeting Quantum Transition States. We work with enzyme inhibitors in a unique way, continually developing … Type: | 2 | 1 | 2 | 19 |
 | KOELIS Advancing Prostate Care KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment. Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full … Type: | 12 | 7 | 5 | 112 |
 | LA CLINIQUE E-SANTÉ [Automatic translation follows] Mental health accessible to all, at every stage of your life We believe that psychological well-being is the foundation of the health capital of every human being. 💙 Our Mission: to create a more human and personalized approach to Mental Health to make it accessible to as many people as possible. The E-Health Clinic is: 🧠 A curative solution 🙂 A therapy based on writing, video and exchange with humans 🕑 An immersive approach 24/7 🚀 Effective care, fast results 🤝 The assurance of follow-up with an expert psychologist according to your problem 📱 Follow-up accessible everywhere, … Type: | 2 | 1 | 1 | 24 |
 | Molecular Assemblies, Inc. DNA Synthesis Uncompromised Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented Fully Enzymatic Synthesis (or FESTM), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego. *Fully Enzymatic Synthesis and FES are the trademarks of … Type: | 1 | 0 | 0 | 47 |
 | ONA Therapeutics First-in-class ADCs tailor designed to attack advanced cancer Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients. Our approach combines privileged biology with Ona’s expertise in biologics. Together, we craft ADCs and antibody therapies, aiming to provide effective new treatments for patients with no remaining alternatives. Type: | 1 | 0 | 1 | 36 |
 | Mereo BioPharma Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments. Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. We are driven by a true understanding of the critical nature of our mission. We harness the power of science; with our knowledge of the rare diseases we seek to treat and deep relationships with all our stakeholders to create new therapeutic possibilities for people who need them. We do this in a focused … Type: | 3 | 0 | 2 | 45 |
 | Anima Biotech Anima is a Tech.Bio company at the intersection of mRNA biology and AI. We are advancing the mRNA Lightning platform for the discovery of small molecule mRNA drugs and novel mRNA biology targets. Built from the ground up with over a decade of expertise in mRNA biology, the platform integrates mRNA biology with AI imaging technologies to visualize the entire life cycle of mRNA in cells and decode the mRNA biology underlying a disease. Utilizing millions of images from both healthy and diseased cells, we train disease-specific mRNA image analysis neural networks to recognize a disease signature, an mRNA biology … Type: | 4 | 0 | 3 | 68 |
 | Genomadix Lab Quality Results Without The Lab! Revolutionizing diagnostics with fast, portable, and accurate DNA results. Based in Ottawa, Canada, Genomadix Inc. is a pioneer in real-time qPCR point of need technology, dedicated to the highest level of customer satisfaction, quality, and support, maintaining ISO 13485 medical device development and manufacturing standards certification. The Genomadix Cube is a real-time polymerase chain reaction (PCR) molecular diagnostic instrument capable of performing tests for precision medicine genotyping and environmental targets on a sample-to-result platform. The portable size, ease of use, and on-demand processing capability enables users to generate time-critical results in approximately one hour. … Type: | 0 | 0 | 0 | 32 |
 | REGEMAT 3D Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures. From Researcher to Researchers. REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life. bioprinting, regenerative medicine, biotechnology, and tissue engineering Type: | 5 | 0 | 2 | 25 |
 | Aptamer Group We develop Optimer® binders to enable innovation across the life science industry. Aptamer Group develops Optimer® binders to enable innovation in the life science industry. Get our newsletter: https://aptamergroup.com/newsletter Research and Development, Assay Development, Custom development, Drug development, Custom reagents, Agriculture testing, Aptamers, Biomarker discovery, Affinity ligands, Environmental testing, Affinity chromatography ligands, ADCs / AOCs, QC reagents, Diagnostic tools, and Targeted delivery Type: | 4 | 0 | 4 | 37 |
 | Colorifix Unlocking nature's pigments for the global dyeing industry We bring colour to life. Colorifix has developed a revolutionary dyeing process to help the textile industry dramatically reduce its environmental impact in a cost-effective manner. Using synthetic biology we produce, deposit and fix dyes biologically, avoiding harmful chemicals whilst reducing water, energy and waste. Let's rethink industrial dyeing. Contact us today to discuss how Colorifix can fulfil your coloration requirements. Type: | 13 | 5 | 11 | 96 |
 | Medherant Limited Medherant is a clinical-stage company developing innovative treatments using its novel transdermal drug delivery technology, the TEPI Patch, which is based on a proprietary adhesive developed by its scientists. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. The adhesive has a high drug loading capacity, so a smaller quantity of adhesive is needed to deliver a therapeutic dose; the patch can therefore be thinner and more flexible. It also enables excipients, such as permeation enhancers, to be included in the adhesive so the … Type: | 2 | 0 | 1 | 16 |
 | TrakCel Transforming Cellular Orchestration for Cell & Gene Therapy. Join us. See the journey. TrakCel design, deploy and support digital Cellular Orchestration Solutions that track and manage all the components of the Cell and Gene Therapy supply chain, helping therapy developers to deliver therapies to patients safely and efficiently for both clinical and commercial stage therapies. For each Advance Therapy Patient journey, from sample collection through logistics, manufacturing and final treatment, TrakCel's flagship platform, OCELLOS orchestrates every step, providing a comprehensive chain of custody, chain of identity and traceability throughout. Always remembering there is a patient at the end of everything … Type: | 8 | 1 | 6 | 96 |
 | PBD Biotech PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. One quarter of the world’s population is infected with latent tuberculosis (LTBI), also known as inactive tuberculosis. One in ten people with LTBI will progress to active TB disease. It is essential to develop newer diagnostic tests with significantly increased predictive value for the development of active disease among those who are infected than the currently available tests for LTBI (WHO, 2017). At PBD Biotech, our mission is to support the scale-up of latent … Type: | 9 | 1 | 5 | 12 |
 | Green Common Green Common is the world’s first plant-based concept store to create a revolutionary food and lifestyle experience by introducing some of the most advanced global foodtech innovations. Its sales network has spread to over 10 countries and regions. Vegan, vegetarian, sustainability, food technology, food innovation, wholesale, distribution, marketing, branding, nutrition, green solution, corporate solutions, plant based, food 2.0, Beyond Burger, Marketing, Catering, Omnipork, and Alternative Protein Type: | 0 | 0 | 0 | 20 |
 | Neumora Pioneering a new era of medicines for brain diseases Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism … Type: | 2 | 0 | 2 | 128 |
 | Biotrains CONNECT COLLABORATE EVOLVE Biotrains is world's leading provider of business conferences, training, managed events and Consulting services for Pharmaceutical, Biotech, Healthcare and Medical Device industry. We at Biotrains recognize that knowledge is power and continuous learning is fundamental for the success of all business and academia. We deliver world-class content and expert knowledge that our clients demand to outshine in their professional roles giving a competitive advantage to their organization. We organize specialized technical events in areas including • Lyophilization/Freeze Drying • Bioprocess Development & Manufacturing • Drug Development, Drug Discovery • Diagnostics & Personalized Medicine • Healthcare, Home Healthcare … Type: | 4 | 0 | 4 | 35 |
 | Béa Fertility Startup building the first clinical grade fertility treatment | Increasing access to effective and affordable treatments The future of fertility care is here. Affordable, at-home ICI-based fertility treatment designed to help you get you pregnant. Fertility and Medical Device Type: | 5 | 2 | 2 | 17 |
 | Bicycle Therapeutics Precision-Guided Therapeutics Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating zelenectide pevedotin, previously BT8009, a Bicycle® Toxin Conjugate (BTC®) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC … Type: | 7 | 2 | 2 | 283 |
 | Aptissen SA Aptissen delivers orthobiologic solutions to joint medical specialists. Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors' network among more than 90 countries including Europe, South America, Canada, Middle East and Asia. Aptissen's team revolutionized the viscosupplement market with Synolis VA and his … Type: | 1 | 0 | 1 | 49 |
 | Twist Bioscience Synthetic DNA for Health & Sustainability Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise … Type: | 27 | 6 | 18 | 1,071 |
Startup